Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
about
Role of KCNMA1 in breast cancer.Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitorsSelective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signalingAndrogen receptor overexpression induces tamoxifen resistance in human breast cancer cells.AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.Androgen and estrogen receptor-mediated mechanisms of testosterone action in male rat pelvic autonomic gangliaAndrogen receptor as a targeted therapy for breast cancer.The Role of Androgen Receptor in Breast Cancer.Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activationDehydroepiandrosterone, androgens and the mammary gland.Expression of androgen receptor splice variants in clinical breast cancers.Sex hormone receptor repertoire in breast cancer.Early versus late distant metastasis and adjuvant chemotherapy alone versus both radiotherapy and chemotherapy in molecular apocrine breast cancerAndrogen receptor antagonists: a patent review (2008-2011).Systematic identification of transcription factors associated with patient survival in cancers.A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment.Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy.Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation.Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects.Study on predictive role of AR and EGFR family genes with response to neoadjuvant chemotherapy in locally advanced breast cancer in Indian women.Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial†Evaluation of Prenatal Exposure to Bisphenol Analogues on Development and Long-Term Health of the Mammary Gland in Female Mice
P2860
Q31086046-88C88E19-3408-4FC3-BE40-1F260D7C5571Q33266857-AA0D3BBF-F7DC-436F-9E7F-43FACF00E33AQ33338236-3EA85520-31D6-44FD-BB80-7805C670785CQ33966915-A384A591-0F22-4F00-AC88-E30177AD608DQ34369138-D77074E5-9418-4ABC-A054-0FEABE9430CCQ35112392-91FBDEDF-C4A0-46B5-ACBD-279980BD2354Q35858203-C0ECD7FC-1024-426F-A490-6E4274B77B44Q36049640-AD2A5F84-F971-4EEF-9E12-400529A0F3F4Q36135807-DAD7DD3C-2632-46B1-A32F-BBC69B97C7CDQ36275556-F25807C8-7924-4C12-9747-9CAF71F19F90Q36367151-14641E8A-86F7-47C2-A2FA-B816E53AB3C1Q36393201-05CF2C37-F82D-4AEB-9754-ACA5E195A72CQ36533630-E62D6C19-07F5-48B5-8D75-F2C53371CF78Q36689084-4BD60D0B-1C80-4CD2-A0E7-7E034DC1377AQ37353645-48B3DA83-D848-43DF-88A5-CDF1B2361E5AQ37580136-7CC13D6E-C5F5-49B7-B8D7-95492F0518E1Q38009888-432F3D70-9C77-47A3-AD77-2A3421B7EF05Q38354101-EBCEEF23-9214-429F-9C03-EFD5EAF70A03Q38973780-8563B932-4D2A-4928-AA88-C5DB7DDDDB83Q39005392-F61ED28D-2038-4719-BF3D-807EED5E10F5Q39877528-2958725C-833A-4C57-866D-393C4085F69FQ42182106-427BAB16-7C6A-4C51-8A92-CECA3CE1DDFAQ54375700-968427E1-B7CF-42DF-A50D-2592FDCD7171Q56690209-B74C6DB4-69E1-45E8-98EA-D91CA6D78A32Q58789699-1F376564-18D1-45C2-90CE-5422E9CCBAA9
P2860
Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Decreased androgen receptor le ...... o medroxyprogesterone acetate.
@ast
Decreased androgen receptor le ...... o medroxyprogesterone acetate.
@en
Decreased androgen receptor le ...... o medroxyprogesterone acetate.
@nl
type
label
Decreased androgen receptor le ...... o medroxyprogesterone acetate.
@ast
Decreased androgen receptor le ...... o medroxyprogesterone acetate.
@en
Decreased androgen receptor le ...... o medroxyprogesterone acetate.
@nl
prefLabel
Decreased androgen receptor le ...... o medroxyprogesterone acetate.
@ast
Decreased androgen receptor le ...... o medroxyprogesterone acetate.
@en
Decreased androgen receptor le ...... o medroxyprogesterone acetate.
@nl
P2093
P50
P1433
P1476
Decreased androgen receptor le ...... to medroxyprogesterone acetate
@en
P2093
Amelia A Peters
David J Horsfall
Elisa J Cops
Grant Buchanan
Henry A Simila
Jacqueline M Bentel
Katrina Ramsay
Lisa M Butler
Nicole L Moore
P304
P356
10.1158/0008-5472.CAN-04-3077
P407
P577
2005-09-01T00:00:00Z